Results 161 to 170 of about 9,495 (247)

Plant‐Derived Natural Product Nanodelivery System in Cancer Therapy

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6644-6669, November 2026.
This review comprehensively summarizes the recent progress and emerging concepts in nanotechnology‐based delivery systems for plant‐derived natural products, with a particular focus on their application in precision cancer therapy. ABSTRACT Plant‐derived natural products have emerged as important sources of anticancer agents because of their diverse ...
Changqi Shi   +9 more
wiley   +1 more source

Cuproptosis-associated ncRNAs predict breast cancer subtypes.

open access: yes
BackgroundCuproptosis is a novel copper-dependent mode of cell death that has recently been discovered. The relationship between Cuproptosis-related ncRNAs and breast cancer subtypes, however, remains to be studied.MethodsThe aim of this study was to ...
Xinying Zheng   +8 more
core   +1 more source

Expression of Cuproptosis-related genes in five subtypes.

open access: yes
Expression of Cuproptosis-related genes in five subtypes.
Ruixiu Chen (17782446)   +8 more
core   +1 more source

Investigation of the DSF/Cu Reaction Using HR LCMS and Reactivity Studies

open access: yesChemBioChem, Volume 27, Issue 20, 28 October 2026.
The generation of Cu(II)bis(diethyldithiocarbamate) from the combination of disulfiram and Cu salts, as used in many cuprototic cancer studies, is examined using high‐resolution liquid chromatography‐mass spectroscopy. By monitoring the reaction at different sampling times to determine reaction intermediates and the addition of adduct‐forming traps, a ...
Jordan Lyons, Patrick J. Farmer
wiley   +1 more source

Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley   +1 more source

Cuproptosis as a Potential Therapeutic Target for Steatotic Liver Disease

open access: yes
Steatotic liver disease (SLD) has become one of the most prevalent chronic liver diseases, representing a significant health burden worldwide. The complex pathogenesis of SLD results in a lack of specific therapeutic targets and effective drug treatment ...
Qifei Duan   +11 more
core   +1 more source

Molecular mechanism of Cuproptosis-related genes.

open access: yes
We retrieved 21 genes involved in Cuproptosis from the literature, including CDKN2A, DLD, DLAT, FDX1, GLS, LIAS, LIPT1, MTF1, PDHA1, and PDHB, ATB7B, CUTC, GRX1, MT1A, MT2A, MT3, XIAP, ATM, PRNP, P53, and SP1.
Ruixiu Chen (17782446)   +8 more
core   +1 more source

Chelation‐Assisted Metal‐Catalyzed Ligation and Cleavage Reactions for Chemical Biology

open access: yesEuropean Journal of Organic Chemistry, Volume 29, Issue 39, 22 October 2026.
Chelation‐assisted transition metal catalysis has emerged as a promising complement to bioorthogonal click chemistry for studying biological processes. By pre‐organizing catalytic metal centers, designed coordinating substrates enhance reactivity and biocompatibility, enabling site‐selective ligation and decaging reactions in complex biological media ...
Emilie Plantiveau   +3 more
wiley   +1 more source

Cuproptosis in Inflammation-Related Respiratory Diseases. [PDF]

open access: yesInt J Mol Sci
Fu Q   +7 more
europepmc   +1 more source

Engineering Inorganic Nanoparticles to Induce Cuproptosis: A New Strategy for Cancer Therapy

open access: yes
Cuproptosis is a newly identified type of copper (Cu)-dependent programmed cell death (PCD), triggered when Cu directly interacts with the lipoylated components of the tricarboxylic acid (TCA) cycle, and it has shown significant antitumor potential ...
Mian Chen   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy